<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03354585</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00040920</org_study_id>
    <nct_id>NCT03354585</nct_id>
  </id_info>
  <brief_title>Mindfulness and Chronic Low Back Pain</brief_title>
  <official_title>Brain Mechanisms Supporting the Modulation of Chronic Low Back Pain by Mindfulness Meditation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the neural mechanisms supporting the modulation of
      chronic low back pain by meditation. The primary hypothesis is that mindfulness will be
      associated with greater activation of the orbitofrontal and anterior cingulate cortices, as
      well as regions involved in the regulation of emotion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic pain affects over 100 million Americans and costs the United States approximately
      $635 billion dollars a year. The widespread use of opioids to treat chronic pain has led to
      the so-called &quot;opioid epidemic&quot;, a phenomenon marked by the exponential growth in opioid
      misuse and addiction. These staggering statistics highlight the importance of developing,
      testing and validating fast-acting, non-pharmacological approaches to treat pain. Mindfulness
      meditation has been found to significantly reduce pain in experimental and clinical settings.
      However, lack of mechanistic data and the assumption that extensive meditation training is
      required to experience analgesia has limited the clinical deployment of this cost-effective
      and narcotic-free treatment. The central aim of the proposed study is to determine the
      specific neural mechanisms that are engaged during mindfulness-based analgesia. This study
      will examine if longer bouts of meditation training will increase meditation-induced brain
      activation (i.e., OFC, sgACC) during chronic low back pain evocation. The knowledge gained
      from this study will provide novel mechanistic insight to better develop and tailor cognitive
      therapeutic interventions to target multiple chronic pain conditions.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>One group - Mindfulness Meditation training Other group - Meditation training Other group - Book Listening Control</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral Blood Flow (average blood perfusion; mL blood/100 grams tissue/minute)</measure>
    <time_frame>There will be up to 4 fMRI sessions. From the date of providing signed, informed consent, study volunteers will have up to 2 months to complete study intervention sessions and MRI scanning.</time_frame>
    <description>Changes in cerebral blood flow will be assessed during pseudo continuous arterial spin labeling fMRI during their respective manipulations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale Pain Ratings</measure>
    <time_frame>During the four fMRI sessions. After providing informed consent, study participants will have up to two months to complete all fMRI scanning.</time_frame>
    <description>Visual analog scale (VAS) pain ratings will be assessed in response to the straight leg raise test and lying supine in the MRI scanner.
Psychophysical Assessment of Pain: As previously in all of our previous pain studies, pain intensity and unpleasantness ratings will be assessed with a Visual Analog Scale. These scales 1) provide reliably separate assessment of experimental and clinical pain intensity and unpleasantness, 2) are internally consistent, and 3) approximate ratio scale measurement accuracy. The minimum rating (&quot;0&quot;) is designated as &quot;no pain&quot; whereas the maximum (&quot;10&quot;) is labeled as &quot;most intense imaginable&quot; or &quot;most unpleasant imaginable&quot;.
Higher numbers correspond to higher perceived pain</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Mindfulness Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study volunteers will participate in a twelve-session mindfulness training regimen. In brief, subjects will be taught that perceived sensory events are &quot;momentary&quot; and &quot;fleeting&quot; and do not require further evaluation. There will be an emphasis on breath focus and altering one's perspective of discursive sensory events. This intervention has been found to reliably attenuate the subjective experience of pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Meditation Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study volunteers will participate in a twelve-session meditation training regimen. In brief, subjects will be taught to take deep breaths every few minutes to facilitate hypothesized descending inhibition of discursive sensory events. There will be an emphasis on breathing rate focus throughout each intervention session. This intervention has been found to reliably attenuate the subjective experience of pain.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Book Listening Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study volunteers will listen to an audio recording of the Natural History of Selborne across each session.This 12 session intervention is meant to provide the control attention to the facilitator, room setting, social support, conditioning, and the time elapsed during the other respective interventions. We do not expect that this group will demonstrate significant cerebral blood flow changes as a function of the intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness training</intervention_name>
    <description>A well-validated brief mindfulness-based mental training regimen [20 min/session(s)] will be used to teach patients to independently practice mindfulness. Participants will be asked to close their eyes acknowledge distracting thoughts and feelings.</description>
    <arm_group_label>Mindfulness Group</arm_group_label>
    <other_name>mental training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Meditation training</intervention_name>
    <description>A well-validated brief meditation-based mental training regimen [20 min/session(s)] will be used to teach patients to independently practice breathing meditation. Participants will be asked to close their eyes and take a deep breath every few minutes.</description>
    <arm_group_label>Meditation Group</arm_group_label>
    <other_name>mental training</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Book Listening Control</intervention_name>
    <description>Study volunteers will listen to The Natural History and Antiquities of Selborne throughout the intervention.</description>
    <arm_group_label>Book Listening Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria are:

          -  Participants must have a medical evaluation that shows the source of low-back pain is
             associated with at least one degenerated, torn or herniated lumbar disc with a minimum
             Grade III disc degeneration. Study physicians will confirm diagnosis.

          -  Participants must be between the ages of 18-65 years.

          -  Participants must rate their daily chronic pain intensity at a 3 or greater on 0-10
             visual analog scale.

          -  Participants must have experienced their radicular pain for at least 6 months
             duration.

          -  They must not be participating in any other pain management procedures during the
             study period.

          -  Participants must not have had back surgery within the last year before their
             enrollment into the study.

          -  Participants must not have had any other sensory or motor deficits that precludes
             participation in this study.

          -  Participants must be right-handed.

          -  Participants must have no prior meditative experience/

        Exclusion criteria:

          -  Participants will be excluded from the study if they have known anomalies of the
             central nervous system including: stroke, dementia, aneurysm, a personal history of
             psychosis.

          -  Participants will be excluded from the study if they test positive for opiates before
             each MRI testing session.

          -  Participants that have metal implants including ferrous arterial stints or coils,
             spinal stimulators, pacemakers, or defibrillators, permanently implanted hearing
             aides, bullets, BBs, or pellets, retinal eye implants, infusion pump for insulin or
             other medicines, ferrous surgical clips, staples, metal sutures, orthopedic hardware
             above or including the shoulders, body piercings that cannot be removed.

          -  Participants will be excluded from the study if they are claustrophobic.

          -  Participants that do not produce positive straight leg test (i.e. a test is considered
             positive when the person reports reproducible pain at 40 degrees of hip flexion or
             less).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fadel Zeidan, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bill Vaughan, PhD</last_name>
    <phone>336-716-9302</phone>
    <email>zeidanlab@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fadel Zeidan, PhD</last_name>
      <phone>336-716-4284</phone>
      <email>fzeidan@wakehealth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Apkarian AV, Krauss BR, Fredrickson BE, Szeverenyi NM. Imaging the pain of low back pain: functional magnetic resonance imaging in combination with monitoring subjective pain perception allows the study of clinical pain states. Neurosci Lett. 2001 Feb 16;299(1-2):57-60.</citation>
    <PMID>11166937</PMID>
  </reference>
  <reference>
    <citation>Bruno PA, Millar DP, Goertzen DA. Inter-rater agreement, sensitivity, and specificity of the prone hip extension test and active straight leg raise test. Chiropr Man Therap. 2014 Jun 16;22:23. doi: 10.1186/2045-709X-22-23. eCollection 2014.</citation>
    <PMID>24982755</PMID>
  </reference>
  <reference>
    <citation>Chen X, Spaeth RB, Freeman SG, Scarborough DM, Hashmi JA, Wey HY, Egorova N, Vangel M, Mao J, Wasan AD, Edwards RR, Gollub RL, Kong J. The modulation effect of longitudinal acupuncture on resting state functional connectivity in knee osteoarthritis patients. Mol Pain. 2015 Oct 29;11:67. doi: 10.1186/s12990-015-0071-9.</citation>
    <PMID>26511911</PMID>
  </reference>
  <reference>
    <citation>Cropley M, Ussher M, Charitou E. Acute effects of a guided relaxation routine (body scan) on tobacco withdrawal symptoms and cravings in abstinent smokers. Addiction. 2007 Jun;102(6):989-93.</citation>
    <PMID>17523994</PMID>
  </reference>
  <reference>
    <citation>Eisenach JC, Rauck RL, Curry R. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain. 2003 Sep;105(1-2):65-70.</citation>
    <PMID>14499421</PMID>
  </reference>
  <reference>
    <citation>Eisenach JC, Thomas JA, Rauck RL, Curry R, Li X. Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans. Pain. 2004 Feb;107(3):207-12.</citation>
    <PMID>14736582</PMID>
  </reference>
  <reference>
    <citation>Fardon DF. Nomenclature and classification of lumbar disc pathology. Spine (Phila Pa 1976). 2001 Mar 1;26(5):461-2.</citation>
    <PMID>11242371</PMID>
  </reference>
  <reference>
    <citation>Fardon DF, Williams AL, Dohring EJ, Murtagh FR, Gabriel Rothman SL, Sze GK. Lumbar disc nomenclature: version 2.0: Recommendations of the combined task forces of the North American Spine Society, the American Society of Spine Radiology and the American Society of Neuroradiology. Spine J. 2014 Nov 1;14(11):2525-45. doi: 10.1016/j.spinee.2014.04.022. Epub 2014 Apr 24. Review.</citation>
    <PMID>24768732</PMID>
  </reference>
  <reference>
    <citation>Hsieh CY, Walker JM, Gillis K. Straight-leg-raising test. Comparison of three instruments. Phys Ther. 1983 Sep;63(9):1429-33.</citation>
    <PMID>6611664</PMID>
  </reference>
  <reference>
    <citation>Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain. 2010 Sep;150(3):390-400. doi: 10.1016/j.pain.2010.02.033. Epub 2010 Mar 23.</citation>
    <PMID>20334973</PMID>
  </reference>
  <reference>
    <citation>Kwong EH, Virani N, Robert M, Gerry K, Harding A, Rose MS, Dukelow SP, Barton PM. Inter-rater reliability of the Active Straight-Leg Raise and One-Leg Standing tests in non-pregnant women. J Rehabil Med. 2013 Nov;45(10):1058-64. doi: 10.2340/16501977-1213.</citation>
    <PMID>23995959</PMID>
  </reference>
  <reference>
    <citation>Lazar N (2008) The Statistical Analysis of Functional MRI Data. New York, New York: Springer.</citation>
  </reference>
  <reference>
    <citation>Loggia ML, Kim J, Gollub RL, Vangel MG, Kirsch I, Kong J, Wasan AD, Napadow V. Default mode network connectivity encodes clinical pain: an arterial spin labeling study. Pain. 2013 Jan;154(1):24-33. doi: 10.1016/j.pain.2012.07.029. Epub 2012 Oct 27.</citation>
    <PMID>23111164</PMID>
  </reference>
  <reference>
    <citation>Mens JM, Vleeming A, Snijders CJ, Stam HJ, Ginai AZ. The active straight leg raising test and mobility of the pelvic joints. Eur Spine J. 1999;8(6):468-73.</citation>
    <PMID>10664304</PMID>
  </reference>
  <reference>
    <citation>Nalamachu S, Rauck RL, Hale ME, Florete OG Jr, Robinson CY, Farr SJ. A long-term, open-label safety study of single-entity hydrocodone bitartrate extended release for the treatment of moderate to severe chronic pain. J Pain Res. 2014 Nov 21;7:669-78. doi: 10.2147/JPR.S71536. eCollection 2014.</citation>
    <PMID>25473308</PMID>
  </reference>
  <reference>
    <citation>North JM, Hong KS, Rauck RL. The Effect of a Novel form of Extended-Release Gabapentin on Pain and Sleep in Fibromyalgia Subjects: An Open-Label Pilot Study. Pain Pract. 2016 Jul;16(6):720-9. doi: 10.1111/papr.12319. Epub 2015 Jun 8.</citation>
    <PMID>26059271</PMID>
  </reference>
  <reference>
    <citation>Pantano P, Mainero C, Lenzi D, Caramia F, Iannetti GD, Piattella MC, Pestalozza I, Di Legge S, Bozzao L, Pozzilli C. A longitudinal fMRI study on motor activity in patients with multiple sclerosis. Brain. 2005 Sep;128(Pt 9):2146-53. Epub 2005 May 18.</citation>
    <PMID>15901646</PMID>
  </reference>
  <reference>
    <citation>Quiton RL, Keaser ML, Zhuo J, Gullapalli RP, Greenspan JD. Intersession reliability of fMRI activation for heat pain and motor tasks. Neuroimage Clin. 2014 Jul 22;5:309-21. doi: 10.1016/j.nicl.2014.07.005. eCollection 2014.</citation>
    <PMID>25161897</PMID>
  </reference>
  <reference>
    <citation>Rauck RL. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone. Drugs. 2013 Aug;73(12):1297-306. doi: 10.1007/s40265-013-0084-5. Review.</citation>
    <PMID>23881667</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Shaibani A, Biton V, Simpson J, Koch B. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb;23(2):150-8.</citation>
    <PMID>17237664</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Potts J, Xiang Q, Tzanis E, Finn A. Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain. Postgrad Med. 2016 Jan;128(1):1-11. doi: 10.1080/00325481.2016.1128307. Epub 2015 Dec 22.</citation>
    <PMID>26634956</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Kapural L, Cohen SP, North JM, Gilmore CA, Zang RH, Boggs JW. Peripheral nerve stimulation for the treatment of postamputation pain--a case report. Pain Pract. 2012 Nov;12(8):649-55. doi: 10.1111/j.1533-2500.2012.00552.x. Epub 2012 May 2.</citation>
    <PMID>22548686</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. J Opioid Manag. 2006 May-Jun;2(3):155-66. Erratum in: J Opioid Manag. 2006 Sep-Oct;2(5):276.</citation>
    <PMID>17319449</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. J Opioid Manag. 2006 Nov-Dec;2(6):325-8, 331-3.</citation>
    <PMID>17326594</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R; Ziconotide 301 Study Group. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage. 2006 May;31(5):393-406.</citation>
    <PMID>16716870</PMID>
  </reference>
  <reference>
    <citation>Rauck RL, Hale ME, Bass A, Bramson C, Pixton G, Wilson JG, Setnik B, Meisner P, Sommerville KW, Malhotra BK, Wolfram G. A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment. Pain. 2015 Sep;156(9):1660-9. doi: 10.1097/j.pain.0000000000000230.</citation>
    <PMID>25993547</PMID>
  </reference>
  <reference>
    <citation>Rebain R, Baxter GD, McDonough S. A systematic review of the passive straight leg raising test as a diagnostic aid for low back pain (1989 to 2000). Spine (Phila Pa 1976). 2002 Sep 1;27(17):E388-95. Review.</citation>
    <PMID>12221373</PMID>
  </reference>
  <reference>
    <citation>Roussel NA, Nijs J, Truijen S, Smeuninx L, Stassijns G. Low back pain: clinimetric properties of the Trendelenburg test, active straight leg raise test, and breathing pattern during active straight leg raising. J Manipulative Physiol Ther. 2007 May;30(4):270-8.</citation>
    <PMID>17509436</PMID>
  </reference>
  <reference>
    <citation>Skup M. Longitudinal fMRI analysis: A review of methods. Stat Interface. 2010;3(2):232-252.</citation>
    <PMID>22655113</PMID>
  </reference>
  <reference>
    <citation>Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Català E, Bryce DA, Coyne PJ, Pool GE; Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002 Oct 1;20(19):4040-9.</citation>
    <PMID>12351602</PMID>
  </reference>
  <reference>
    <citation>Summers B, Malhan K, Cassar-Pullicino V. Low back pain on passive straight leg raising: the anterior theca as a source of pain. Spine (Phila Pa 1976). 2005 Feb 1;30(3):342-5.</citation>
    <PMID>15682017</PMID>
  </reference>
  <reference>
    <citation>Ussher M, Cropley M, Playle S, Mohidin R, West R. Effect of isometric exercise and body scanning on cigarette cravings and withdrawal symptoms. Addiction. 2009 Jul;104(7):1251-7. doi: 10.1111/j.1360-0443.2009.02605.x.</citation>
    <PMID>19563567</PMID>
  </reference>
  <reference>
    <citation>Wallace MS, Rowbotham MC, Katz NP, Dworkin RH, Dotson RM, Galer BS, Rauck RL, Backonja MM, Quessy SN, Meisner PD. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 2002 Dec 10;59(11):1694-700.</citation>
    <PMID>12473754</PMID>
  </reference>
  <reference>
    <citation>Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain. 2005 Oct;117(3):450-61.</citation>
    <PMID>16154274</PMID>
  </reference>
  <reference>
    <citation>Wasan AD, Loggia ML, Chen LQ, Napadow V, Kong J, Gollub RL. Neural correlates of chronic low back pain measured by arterial spin labeling. Anesthesiology. 2011 Aug;115(2):364-74. doi: 10.1097/ALN.0b013e318220e880.</citation>
    <PMID>21720241</PMID>
  </reference>
  <reference>
    <citation>White G (1908) Natural History and Antiquities of Selborne. London, England: Cassell and Company.</citation>
  </reference>
  <reference>
    <citation>Zeidan F, Johnson SK, Gordon NS, Goolkasian P. Effects of brief and sham mindfulness meditation on mood and cardiovascular variables. J Altern Complement Med. 2010 Aug;16(8):867-73. doi: 10.1089/acm.2009.0321.</citation>
    <PMID>20666590</PMID>
  </reference>
  <reference>
    <citation>Zeidan F, Lobanov OV, Kraft RA, Coghill RC. Brain mechanisms supporting violated expectations of pain. Pain. 2015 Sep;156(9):1772-85. doi: 10.1097/j.pain.0000000000000231.</citation>
    <PMID>26083664</PMID>
  </reference>
  <reference>
    <citation>Zeidan F, Johnson SK, Diamond BJ, David Z, Goolkasian P. Mindfulness meditation improves cognition: evidence of brief mental training. Conscious Cogn. 2010 Jun;19(2):597-605. doi: 10.1016/j.concog.2010.03.014. Epub 2010 Apr 3.</citation>
    <PMID>20363650</PMID>
  </reference>
  <reference>
    <citation>Zeidan F, Martucci KT, Kraft RA, Gordon NS, McHaffie JG, Coghill RC. Brain mechanisms supporting the modulation of pain by mindfulness meditation. J Neurosci. 2011 Apr 6;31(14):5540-8. doi: 10.1523/JNEUROSCI.5791-10.2011.</citation>
    <PMID>21471390</PMID>
  </reference>
  <reference>
    <citation>Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG, Coghill RC. Mindfulness Meditation-Based Pain Relief Employs Different Neural Mechanisms Than Placebo and Sham Mindfulness Meditation-Induced Analgesia. J Neurosci. 2015 Nov 18;35(46):15307-25. doi: 10.1523/JNEUROSCI.2542-15.2015.</citation>
    <PMID>26586819</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2017</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mindfulness</keyword>
  <keyword>fMRI</keyword>
  <keyword>Pain</keyword>
  <keyword>low back</keyword>
  <keyword>radicular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

